BIORETAIN Trademark

Trademark Overview


On Thursday, May 6, 2021, a trademark application was filed for BIORETAIN with the United States Patent and Trademark Office. The USPTO has given the BIORETAIN trademark a serial number of 90694202. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by BioStem Technologies, Inc.. The BIORETAIN trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
bioretain

General Information


Serial Number90694202
Word MarkBIORETAIN
Filing DateThursday, May 6, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6902573
Registration DateTuesday, November 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesHuman allograft tissue
Pseudo MarkBIO RETAIN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 9, 2021
Primary Code005
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateSaturday, January 1, 2022

Trademark Owner History


Party NameBioStem Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPompano Beach, GA 33469

Party NameBioStem Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPompano Beach, GA 33469

Party NameBioStem Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPompano Beach, GA 33469

Trademark Events


Event DateEvent Description
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, October 8, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 7, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 1, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 20, 2022USE AMENDMENT FILED
Saturday, October 1, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 20, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 10, 2022ASSIGNED TO EXAMINER
Monday, August 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 10, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords


bioretain tissue allograft human